Retsevmo ( Selpercatinib ) for the treatment of advanced RET fusion-positive Non-Small Cell Lung Cancer (NSCLC)
CPE point: 1 per event
This is an in-service training for the staff of St.Teresa's Hospital & St. Paul's Hospital
Date:
2025-07-10
Time:
5:30pm to 6:30pm
Organising Institute:
St. Teresa's Hospital & St. Paul’s Hospital
Speaker:
BSc Mr Philip Li, Manager, Medical Affairs – Oncology, Eli Lilly
Related CPE Activities:
